Fundraising FoxManaT Bio
Baltimore, US · Founded 2020 · Delaware corporation · 5 known investors
Find your way into ManaT Bio
Sign up to see every warm intro you have to ManaT Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ManaT Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CG
Cary G. PfefferNamed on SEC filing
RJ
R. Jacob VogelsteinNamed on SEC filing
AV
Andrea Van ElsasNamed on SEC filing
RC
Raymond CamahortNamed on SEC filing
JN
Jack NielsenNamed on SEC filing
AP
Andrew PardollNamed on SEC filing
Investors · 5
Catalio Capital ManagementreportedNew York
How we know: funding news · Not right? Tell us
Novo HoldingsreportedHellerup · $1.1M – $54M
How we know: funding news · Not right? Tell us
Revo CapitalreportedIstanbul · $250K – $5M
How we know: press coverage · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5M
How we know: funding news · Not right? Tell us
Vivo CapitalreportedPalo Alto · $10M – $50M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$72.1M disclosed across 1 round · 2023
▶$72.1MraisedOct 2023 · 9 investors · BiotechnologyRule 506(b)
▶$72.1MraisedOct 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cary G. PfefferExecutive Officer, Director
- R. Jacob VogelsteinDirector
- Andrea Van ElsasExecutive Officer, Director
- Raymond CamahortDirector
- Jack NielsenDirector
- Andrew PardollDirector
- ManaT Holdings, LLCPromoter
- Offering amount
- $153M
- Amount sold
- $72.1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are ManaT Bio's investors?
- ManaT Bio's investors include Catalio Capital Management, Novo Holdings, Revo Capital, Third Rock Ventures, Vivo Capital.
- How much funding has ManaT Bio raised?
- ManaT Bio has disclosed $72.1M raised across 1 round.
- Where is ManaT Bio headquartered?
- ManaT Bio is headquartered in Baltimore, US.